Cargando…
Incidence of Type 2 Diabetes in Patients With Chronic Hepatitis C Receiving Interferon-Based Therapy
Autores principales: | Tsai, Ming-Chieh, Kao, Kai-Liang, Huang, Hui-Chun, Chen, Weishan, Fang, Chun-Kai, Sung, Fung-Chang, Wu, Shu-I, Stewart, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245353/ https://www.ncbi.nlm.nih.gov/pubmed/32209648 http://dx.doi.org/10.2337/dc19-1704 |
Ejemplares similares
-
Metformin and the Incidence of Cancer in Patients With Diabetes: A Nested Case-Control Study
por: Wang, Shu-Yi, et al.
Publicado: (2013) -
The Relationship of Serum Soluble Receptor for Advanced Glycation End Products (sRAGE) and Carboxymethyl Lysine (CML) to the Incidence of Diabetic Nephropathy in Persons With Type 1 Diabetes
por: Klein, Ronald, et al.
Publicado: (2017) -
Degree of Cardiometabolic Risk Factor Normalization in Individuals Receiving Bariatric Surgery: Evidence From NHANES 2015–2018
por: Hong, Young-Rock, et al.
Publicado: (2021) -
Discovery of a Biomarker Signature That Reveals a Molecular Mechanism Underlying Diabetic Kidney Disease via Organ Cross Talk
por: Wu, I-Wen, et al.
Publicado: (2022) -
Material Need Insecurity and Its Concurrent Barriers to Diabetes Management Among Low-Income Latino Adults Receiving Medical Care
por: Mullin, Briga, et al.
Publicado: (2019)